LPL Financial LLC Reduces Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

LPL Financial LLC lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,059 shares of the medical instruments supplier’s stock after selling 17,049 shares during the period. LPL Financial LLC’s holdings in DENTSPLY SIRONA were worth $1,465,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in XRAY. Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the first quarter worth $25,000. Colonial Trust Co SC purchased a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth $26,000. True Wealth Design LLC raised its position in shares of DENTSPLY SIRONA by 866.7% in the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after buying an additional 1,950 shares in the last quarter. Allworth Financial LP raised its position in shares of DENTSPLY SIRONA by 175.8% in the first quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier’s stock worth $54,000 after buying an additional 2,517 shares in the last quarter. Finally, Quarry LP raised its position in shares of DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after buying an additional 780 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $14.66 on Friday. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The firm has a 50-day moving average of $15.27 and a 200-day moving average of $15.52. The firm has a market cap of $2.92 billion, a P/E ratio of -3.09, a P/E/G ratio of 0.87 and a beta of 0.94. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same period last year, the business posted $0.49 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.4%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -13.50%.

Analysts Set New Price Targets

A number of research firms recently commented on XRAY. Piper Sandler reduced their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 30th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Barrington Research reduced their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, August 8th. UBS Group reduced their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Finally, Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $18.64.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.